Effect of tocilizumab versus standard of care in adults hospitalized with moderate-severe COVID-19 pneumonia.

Aomar-Millán, Ismael F; Salvatierra, Juan; Raya Álvarez, Enrique

Effect of tocilizumab versus standard of care in adults hospitalized with moderate-severe COVID-19 pneumonia. / Efecto del tocilizumab frente a cuidado estándar en pacientes adultos hospitalizados con neumonía por COVID-19 moderada-grave.

Aomar-Millán, Ismael F; Salvatierra, Juan; Raya Álvarez, Enrique.

Aomar-Millán IF; Servicio de Medicina Interna, Hospital Universitario Clínico San Cecilio, Granada, España; Instituto de investigación biosanitaria de Granada ibs.Granada, Granada, España. Electronic address: iaomarmillan@hotmail.com.
Salvatierra J; Servicio de Reumatología, Hospital Universitario Clínico San Cecilio, Granada, España; Instituto de investigación biosanitaria de Granada ibs.Granada, Granada, España.
Raya Álvarez E; Servicio de Reumatología, Hospital Universitario Clínico San Cecilio, Granada, España; Instituto de investigación biosanitaria de Granada ibs.Granada, Granada, España.

Med Clin (Barc) ; 159(8): e54, 2022 10 28.

Article in English, Spanish | MEDLINE | ID: covidwho-2015837

Subject(s)

COVID-19 Drug Treatment; Adult; Antibodies, Monoclonal, Humanized/therapeutic use; Humans; Standard of Care; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment Type of study: Experimental Studies / Prognostic study Limits: Adult / Humans Language: English / Spanish Journal: Med Clin (Barc) Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google